Has Tosha Hedin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $625 in general payments to Tosha Hedin, MD across 27 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tosha Hedin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tosha Hedin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tosha Hedin, MD

Internal Medicine · Rome, GANPI 1801425798

Payments from drug & device makers

$625in general payments, 2019–2025

Across 27 payments — averaging $23.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Incyte Corporation$125
E.r. Squibb & Sons, L.L.C.$90
Regeneron Healthcare Solutions, Inc.$60
Kyowa Kirin, Inc.$42
Johnson & Johnson$40
AVEO Pharmaceuticals, Inc.$34
plus $235 from 12 others

What the payments were for

Food & beverage$52985%
Education$9615%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Incyte Corporation	2	$125
E.r. Squibb & Sons, L.L.C.	5	$90
Regeneron Healthcare Solutions, Inc.	3	$60
Kyowa Kirin, Inc.	2	$42
Johnson & Johnson	2	$40
AVEO Pharmaceuticals, Inc.	1	$34
Daiichi Sankyo Inc.	1	$27
Beone Medicines USA, Inc.	1	$24
Abiomed	1	$23
Bayer	1	$22
Takeda Pharmaceuticals U.S.A., Inc.	1	$21
Deciphera Pharmaceuticals Inc.	1	$21
EMD Serono, Inc.	1	$19
Genentech USA, Inc.	1	$17
Syndax Pharmaceuticals, Inc.	1	$16
Servier Pharmaceuticals LLC	1	$16
Lilly USA, LLC	1	$15
Novartis	1	$14

How this compares

$625 in reported general payments places this provider in the 60th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia →

Medicare billing

Part B allowed, 2024

$80,285

Medicare patients

242

Services billed

731

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate	13	$330
Atorvastatin Calcium	25	$224
Pantoprazole Sodium	20	$196
Metoprolol Tartrate	14	$132
Ondansetron OdtOndansetron	12	$112
Furosemide	14	$108
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	12	$39
Prednisone	17	$35

Paid to pharmacies, not to this prescriber.

Other internal medicine in Rome

Paul BradleySavannah$76.4M
Kimball JohnsonAtlanta$51.1M
Bram WieskopfWoodstock$21.9M
Dwight BlakeUnion City$13.3M
Charlotte Grayson-MathisFayetteville$9.6M
Christopher RecknorGainesville$9.2M
James HarperJohns Creek$9.2M
Robert Springer IiiAtlanta$5.3M
Thomas MoriaritySavannah$4.6M
Charles KempAlbany$2.7M

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →